KKR, Palantir, ONEOK, and Celanese's Earnings On The Horizon: A Preview
- August 05th, 2023
- 440 views
As the financial reporting season heats up, a number of companies are poised to reveal their second-quarter 2023 results, offering insights into their performance and market trends. The lineup for Monday, August 7, includes:
KKR & Co. Inc. (NYSE: KKR), a renowned investment firm known for its diverse portfolio, is set to unveil its Q2 2023 financials ahead of the opening bell on the New York Stock Exchange.
Market analysts are expecting the company to report earnings per share (EPS) of $0.71 on revenue totaling $1.15 billion.
On Friday, $KKR closed at $60.19, reflecting a gain of $0.95 (1.60%).
Palantir Technologies Inc. (NYSE: PLTR), a prominent data analytics company, will share its Q2 2023 earnings after the U.S. market closes.
The consensus estimate points to an EPS of $0.05 with revenue reaching $532.71 million.
$PLTR closed at $18.20 on Friday, down $0.51 (-2.73%).
ONEOK, Inc. (NYSE: OKE), a leading energy company specializing in natural gas and liquids, has plans to disclose its second quarter 2023 earnings post the market's closure.
Analysts are forecasting an EPS of $1.02 and revenue amounting to $4.67 billion.
On Friday, $OKE closed at $65.25, showing a decrease of $0.71 (-1.08%).
Celanese Corporation (NYSE: CE), a major global technology and specialty materials company, is scheduled to release its Q2 2023 earnings results after the close of the New York Stock Exchange.
The consensus EPS estimate is $2.48 on revenue totaling $2.96 billion.
$CE closed at $123.95 on Friday, down $0.46 (-0.37%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026




Member Login